epirubicin hydrochloride injection
amneal-agila, llc - epirubicin hydrochloride (unii: 22966tx7j5) (epirubicin - unii:3z8479zz5x) - epirubicin hydrochloride 50 mg in 25 ml
epirubicin hydrochloride injection
mylan institutional llc - epirubicin hydrochloride (unii: 22966tx7j5) (epirubicin - unii:3z8479zz5x) - epirubicin hydrochloride 50 mg in 25 ml
epirubicin hydrochloride injection solution
greenstone, llc - epirubicin hydrochloride (unii: 22966tx7j5) (epirubicin - unii:3z8479zz5x) - epirubicin hydrochloride 2 mg in 1 ml
epirubicin hydrochloride injection solution
teva parenteral medicines, inc. - epirubicin hydrochloride (unii: 22966tx7j5) (epirubicin - unii:3z8479zz5x) - epirubicin hydrochloride 50 mg in 25 ml
epirubicin ebewe
sandoz new zealand limited - epirubicin hydrochloride 2 mg/ml; - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml excipient: hydrochloric acid sodium chloride water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).
epirubicin accord epirubicin hydrochloride 200mg/100ml concentrated injection vial
accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).
epirubicin accord epirubicin hydrochloride 50mg/25ml concentrated injection vial
accord healthcare pty ltd - epirubicin hydrochloride, quantity: 50 mg - injection, concentrated - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).
epirubicin accord epirubicin hydrochloride 20mg/10ml concentrated injection vial
accord healthcare pty ltd - epirubicin hydrochloride, quantity: 20 mg - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).
epirubicin accord epirubicin hydrochloride 10mg/5ml concentrated injection vial
accord healthcare pty ltd - epirubicin hydrochloride, quantity: 10 mg - injection, concentrated - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).
epirubicin kabi epirubicin hydrochloride 10 mg/5 ml solution for injection vial
fresenius kabi australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases and is indicated for the treatment of:,? breast cancer,? gastric cancer,? ovarian cancer,? small cell lung cancer,? lymphoma (non-hodgkin?s lymphoma),? advanced/metastatic soft tissue sarcoma,? superficial bladder cancer (tis; ta).,in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).